本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

VYNE Therapeutics Inc.

1.34
-0.1100-7.59%
盘后1.420.0800+5.97%19:48 EDT
成交量:46.44万
成交额:64.25万
市值:2,233.10万
市盈率:-1.35
高:1.46
开:1.46
低:1.32
收:1.45
数据加载中...
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report
2023/12/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/20

SEC问询函

Form CORRESP - Correspondence
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/30

重要事件披露

Form 8-K - Current report
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

重要事件披露

8-K - Current report
2023/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]